Toggle Side Panel
Close search

Cystic Fibrosis News Community › Forums › Science and Research › 1st CF Biosimilar of Dornase Alfa Inhalation Solution Approved in Russia

  • Science and Research

    1st CF Biosimilar of Dornase Alfa Inhalation Solution Approved in Russia

    Posted by Community Member on September 25, 2019 at 9:09 am

    Generium and Selexis announced that Russia approved the world’s first biosimilar to Pulmozyme, a dornase alfa inhalation solution, to treat CF patients. Read the full story here.

    What do you think of this news?

    Community Member replied 6 years, 8 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .